EvolveImmune Therapeutics

Biotechnology Research • Branford, Connecticut, United States • 51-100 Employees

Company overview

Headquarters	Branford, Connecticut, United States
Phone number	+12032086584
Website	evolveimmune.com
NAICS	541714
Keywords	Immunooncology, T-Cell Exhaustion, Immunobiologics
Founded	2020
Employees	51-100
Socials

Key Contacts at EvolveImmune Therapeutics

Charles Fuchs

Co-Founder

Shaun Obrien

Associate Director, Translational Sciences

Stephen Bloch

Chief Executive Officer

Yanhuai Ding

Senior Director Cmc Ds/Dp

Astha Bhatia

Senior Director, Clinical Scientist

Michelle Baptiste

Human Resources Director

Agnes Meade

Senior Director, Development Program And Alliance Management

Eric Tam

Senior Director, Research

Martin Preyer

Executive Director Biotherapeutics

Bruce Andrien

Senior Director, Analytical Development

EvolveImmune Therapeutics Email Formats

EvolveImmune Therapeutics uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@evolveimmune.com), used 52.6% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@evolveimmune.com	52.6%
{first name}.{last name}	john.doe@evolveimmune.com	45.6%
{first name}	john@evolveimmune.com	1.8%

About EvolveImmune Therapeutics

EvolveImmune is pioneering a pipeline of unique trispecific T cell engagers with integrated CD2 costimulation. The EVOLVE platform tackles the treatment challenges of cancer cell resistance to current immunotherapies. The company’s lead internal drug candidate, EVOLVE104, will enter the clinic in 2025. We are based in Branford, CT.

EvolveImmune Therapeutics revenue & valuation

Annual revenue	$1,800,000
Revenue per employee	$32,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,800,000
Total funding	$57,400,000

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Director

Senior

Employees by Department

EvolveImmune Therapeutics has 24 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore EvolveImmune Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-12-16	1	$37,400,000
2024-11-29	1	$20,000,000

Funding Insights

$57,400,000

Total funding amount

$20,000,000

Most recent funding amount

Number of funding rounds

EvolveImmune Therapeutics Tech Stack

Discover the technologies and tools that power EvolveImmune Therapeutics's digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

Video players

reCAPTCHA

Security

SiteGround

Hosting

WP Rocket

Caching

Google Maps

Maps

Microsoft 365

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Divi

Page builders

Yoast SEO

SEO

Frequently asked questions

EvolveImmune Therapeutics is located in Branford, Connecticut, US.

You can reach EvolveImmune Therapeutics at +12032086584.

EvolveImmune Therapeutics was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

EvolveImmune Therapeutics has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

EvolveImmune Therapeutics has raised a total of $57,400,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.